IGC logo

IGC

Profile

Full Name

IGC Pharma, Inc.

Ticker Symbol

IGC

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 24, 2006

Indexes

Not included

Website

http://igcpharma.com

Employees

67

Key Details

Price

$0.28(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.34M(+47.64% YoY)

Annual EPS

-$0.22(0.00% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.28
IGC price is $0.28

30-Day Relative Volume

0.51
IGC 30-day relative volume is 0.51

Price Performance

Price Most recent change

0%
IGC {parameterFullLabel} has remained unchanged on Apr 14, 2025

Price YTD change

-17.65%
IGC price is down -17.65% since January 1st

Price 1-year change

-36.36%
IGC price is down -36.36% year-on-year

Price 3-year change

-67.82%
IGC price is down -67.82% over the past 3 years

Price Range

Price All-time high

$71.10
IGC price is currently -99.61% below its historical high of $71.10

Price 3-year low

$0.25
IGC price is currently +12.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$22.31M
IGC market capitalization is $22.31 million

Market cap 3-year change

-49.77%
IGC market capitalization is down -49.77% over the past 3 years

Market cap All-time high

$445.22M
IGC market capitalization is currently -94.99% below its historical high of $445.22 million

Market cap sector rank

28.78%
IGC market capitalization is higher than 28.78% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+19.27%
IGC shares outstanding is up +19.27% year-on-year

Shares Outstanding 3-Year Change

+56.08%
IGC shares outstanding is up +56.08% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.37
IGC beta is 0.37

200-day SMA

$0.36
IGC price is currently -22.52% below its 200-day simple moving average

50-day SMA

$0.30
IGC price is currently -6.48% below its 50-day simple moving average

RSI

44.21
IGC 14-day relative strength index is 44.21

Volume

0.51
IGC 30-day relative volume is 0.51

ATR

$0.02
IGC average true range is $0.02

10-day Historical Volatility

70.98%
IGC 10-day historical volatility is 70.98%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.34M
IGC annual revenue is $1.34 million

Revenue Analysts estimate

$1.25M
IGC annual revenue is currently +7.95% higher than the consensus analysts' forecast

Revenue 1-year change

+47.64%
IGC annual revenue is up +47.64% year-on-year

Revenue Sector rank

13.66%
IGC annual revenue is higher than 13.66% of companies in Healthcare sector

EPS

EPS

-$0.22
IGC annual earnings per share is -$0.22

EPS Analysts estimate

-$0.10
IGC annual earnings per share is currently +120.00% higher than the consensus analysts' forecast

EPS 1-year change

0%
IGC {parameterFullLabel} has remained unchanged year-on-year

EPS Sector rank

77.17%
IGC annual earnings per share is higher than 77.17% of companies in Healthcare sector

Profit

Gross profit

$733.00K
IGC annual gross profit is $733.00 thousand

Gross margin

54.50%
IGC annual gross profit margin is 54.50%

Operating profit

-$9.80M
IGC annual operating income is -$9.80 million

Operating margin

-728.48%
IGC annual operating profit margin is -728.48%

Net income

-$13.00M
IGC annual net profit is -$13.00 million

Net margin

-966.54%
IGC annual net profit margin is -966.54%

Expenses

Total expenses

$11.14M
IGC annual total expenses is $11.14 million

Operating expenses

$10.53M
IGC annual total operating expenses is $10.53 million

Cost of goods sold

$612.00K
IGC annual cost of goods sold is $612.00 thousand

Selling, general & administrative expenses

$6.76M
IGC annual SGA is $6.76 million

Depreciation and amortization

$637.00K
IGC annual depreciation & amortization is $637.00 thousand

Interest expense

-
IGC annual interest expense value is unknown

Income tax

$0.00
IGC annual income tax is $0.00

EBIT & EBITDA

EBIT

-$9.80M
IGC annual earnings before interest & taxes is -$9.80 million

EBITDA

-$9.16M
IGC annual EBITDA is -$9.16 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$9.90M
IGC annual total assets is $9.90 million

Non current assets

$6.20M
IGC annual long term assets is $6.20 million

Current assets

$3.71M
IGC annual total current assets is $3.71 million

Cash and cash equivalents

$1.20M
IGC annual cash & cash equivalents is $1.20 million

Accounts receivable

$39.00K
IGC annual accounts receivable is $39.00 thousand

Inventory

$1.54M
IGC annual inventory is $1.54 million

Liabilities

Total liabilities

$2.58M
IGC annual total liabilities is $2.58 million

Long term liabilities

$241.00K
IGC annual total long term liabilities is $241.00 thousand

Current liabilities

$2.34M
IGC annual total current liabilities is $2.34 million

Accounts payable

$773.00K
IGC annual accounts payable is $773.00 thousand

Debt

Total debt

$345.00K
IGC annual total debt is $345.00 thousand

Total debt 1-year change

-28.27%
IGC annual total debt is down -28.27% year-on-year

Long term debt

$221.00K
IGC annual long term debt is $221.00 thousand

Short term debt

$124.00K
IGC annual short term debt is $124.00 thousand

Equity & Capital

Shareholders equity

$7.32M
IGC annual stockholders equity is $7.32 million

Book value

$7.32M
IGC annual book value is $7.32 million

Retained earnings

-$113.67M
IGC annual retained earnings is -$113.67 million

Working capital

$1.36M
IGC annual working capital is $1.36 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$5.20M
IGC annual cash flow from operations is -$5.20 million

Cash from operations 1-year change

+26.22%
IGC annual cash flow from operations is up +26.22% year-on-year

Cash from investing

-$317.00K
IGC annual cash flow from investing activities is -$317.00 thousand

Cash from investing 1-year change

-34.89%
IGC annual cash flow from investing activities is down -34.89% year-on-year

Cash from financing

$3.52M
IGC annual cash flow from financing activities is $3.52 million

Cash from financing 1-year change

+3424%
IGC annual cash flow from financing activities is up +3424% year-on-year

CAPEX

CAPEX

$515.00K
IGC annual capital expenditures is $515.00 thousand

CAPEX 1-year change

-16.8%
IGC annual capital expenditures is down -16.8% year-on-year

Free Cash Flow

Free cash flow

-$5.71M
IGC annual free cash flow is -$5.71 million

Free cash flow 1-year change

+25.46%
IGC annual free cash flow is up +25.46% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

54.50%
IGC annual gross profit margin is 54.50%

Operating margin

-728.48%
IGC annual operating profit margin is -728.48%

Net margin

-966.54%
IGC annual net profit margin is -966.54%

ROA & ROE

ROA

-96.01%
IGC annual return on assets is -96.01%

ROE

-116.95%
IGC annual return on equity is -116.95%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
IGC price to earnings ratio value is unknown

PE ratio Sector rank

-
IGC price to earnings ratio is unknown

PB Ratio

PB ratio

3.56
IGC price to book ratio is 3.56

PB ratio Sector rank

76.46%
IGC price to book ratio is higher than 76.46% of companies in Healthcare sector

PS Ratio

PS ratio

18.05
IGC price to sales ratio is 18.05

PS ratio Sector rank

85.77%
IGC price to sales ratio is higher than 85.77% of companies in Healthcare sector

Enterprise value

Enterprise value

$22.11M
IGC enterprise value is $22.11 million

Enterprise value Sector rank

33.22%
IGC enterprise value is higher than 33.22% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.92
IGC EV/EBITDA is -2.92

EV/EBITDA Sector rank

26%
IGC EV/EBITDA is higher than 26% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.58
IGC annual current ratio is 1.58

Quick ratio

0.93
IGC annual quick ratio is 0.93

Leverage

Debt to equity

0.02
IGC annual debt to equity ratio is 0.02

Interest coverage ratio

-
IGC annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

3
IGC piotroski f-score is 3

Altman Z-Score

-13.85
IGC altman z-score is -13.85

Analyst ratings

Recent major analysts updates

Mar 6, 25 Alliance Global Partners
Buy
Feb 24, 25 Ascendiant Capital
Buy
Dec 5, 24 Ascendiant Capital
Buy
Sep 3, 24 Ascendiant Capital
Buy
Jul 29, 24 Ascendiant Capital
Buy
Jul 17, 24 Alliance Global Partners
Buy
Jun 21, 24 Ascendiant Capital
Buy

Institutional Ownership

Similar stocks

CMMB logo
Chemomab Therapeutics (CMMB)
KALA logo
Kala Pharmaceuticals (KALA)
NSYS logo
Nortech Systems Incorporated (NSYS)
DRRX logo
DURECT (DRRX)
CalciMedica (CALC)
TENX logo
Tenax Therapeutics (TENX)
LIAN logo
LianBio (LIAN)
LGVN logo
Longeveron (LGVN)
FNCH logo
Finch Therapeutics (FNCH)
  • What is the ticker symbol for India Globalization Capital?
  • Does India Globalization Capital pay dividends?
  • What sector is India Globalization Capital in?
  • What industry is India Globalization Capital in?
  • What country is India Globalization Capital based in?
  • When did India Globalization Capital go public?
  • Is India Globalization Capital in the S&P 500?
  • Is India Globalization Capital in the NASDAQ 100?
  • Is India Globalization Capital in the Dow Jones?
  • When was India Globalization Capital's last earnings report?
  • When does India Globalization Capital report earnings?
  • Should I buy India Globalization Capital stock now?

What is the ticker symbol for India Globalization Capital?

The ticker symbol for India Globalization Capital is NYSE American:IGC

Does India Globalization Capital pay dividends?

No, India Globalization Capital does not pay dividends

What sector is India Globalization Capital in?

India Globalization Capital is in the Healthcare sector

What industry is India Globalization Capital in?

India Globalization Capital is in the Biotechnology industry

What country is India Globalization Capital based in?

India Globalization Capital is headquartered in United States

When did India Globalization Capital go public?

India Globalization Capital's initial public offering (IPO) was on May 24, 2006

Is India Globalization Capital in the S&P 500?

No, India Globalization Capital is not included in the S&P 500 index

Is India Globalization Capital in the NASDAQ 100?

No, India Globalization Capital is not included in the NASDAQ 100 index

Is India Globalization Capital in the Dow Jones?

No, India Globalization Capital is not included in the Dow Jones index

When was India Globalization Capital's last earnings report?

India Globalization Capital's most recent earnings report was on Feb 14, 2025

When does India Globalization Capital report earnings?

The next expected earnings date for India Globalization Capital is Aug 7, 2025

Should I buy India Globalization Capital stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page